دورية أكاديمية

P-275 FOLFOX versus FOLFIRI as second-line treatment after cisplatin-gemcitabine in patients with advanced biliary tract cancers

التفاصيل البيبلوغرافية
العنوان: P-275 FOLFOX versus FOLFIRI as second-line treatment after cisplatin-gemcitabine in patients with advanced biliary tract cancers
المؤلفون: Nichetti, F., Rizzato, M., Bensi, M., Salani, F., Franza, A., Piva, V., Cerantola, R., Chiaravalli, M., Masi, G., Djaballah, S. Ahcene, Barone, D., Vivaldi, C., Bergamo, F., Rota, S., Di Bartolomeo, M., de Braud, F., Niger, M., Lonardi, S.
المصدر: In Annals of Oncology June 2023 34 Supplement 1:S113-S113
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1016/j.annonc.2023.04.331